Dr. Stein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Duarte Rd
City of Hope, Med Oncology Dept
Duarte, CA 91010Phone+1 626-471-3890Fax+1 626-471-7322
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1982 - 1985
- Albert Einstein College of MedicineClass of 1982
Certifications & Licensure
- NY State Medical License 1984 - 2026
- CA State Medical License 2012 - 2021
- MD State Medical License 1985 - 1991
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2014
- Top Doctors:LA Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2013
- Join now to see all
Publications & Presentations
PubMed
- 60 citationsA cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cellsDaniela Castanotto, Min Lin, Claudia M. Kowolik, LiAnn Wang, Xiao-Qin Ren
Nucleic Acids Research. 2015-10-30 - 648 citationsAzithromycin and the risk of cardiovascular death.Wayne A. Ray, Katherine T. Murray, Patrick G. Arbogast, C. Michael Stein
The New England Journal of Medicine. 2012-05-16 - 104 citationsOutpatient Opioid Prescriptions for Children and Opioid-Related Adverse EventsCecilia P. Chung, S. Todd Callahan, William O. Cooper, William D. Dupont, Katherine T. Murray
Pediatrics. 2018-08-01
Journal Articles
- A Stress-Induced Response Complex (SIRC) Shuttles miRNAs, siRNAs, and Oligonucleotides to the NucleusCy Stein, MD, Proceedings of the National Academy of Sciences
Press Mentions
- The World's First Drug Made for Only One PatientOctober 11th, 2019
- Learning from Suramin: A Case Study of NCI’s Much-Hyped Cancer Drug That Crashed and Burned—35 Years AgoAugust 9th, 2019
- Myovant’s Supposed Market Edge in Castrate-Sensitive Prostate Cancer Draws ReservationsMarch 22nd, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: